Why the Administration Should Be Flexible with Medtech Tariffs to Protect Patients and Innovation
Flexibility on tariffs is critical to maintaining medtech as the backbone of the U.S. health care system and an American economic success story.
Global & Trade
Learn more about our Global Affairs work.
Tariffs: Understanding the Nairobi Protocol and related Customs Procedures
Learn how the Nairobi Protocol may support duty-free access for medical devices under new tariffs.
Scott Whitaker Op-Ed: Tariffs Should Spare Vital U.S. MedTech Industry
A powerful op-ed from AdvaMed’s CEO explaining why tariffs could undermine U.S. medtech innovation, jobs, and patient care—and what must be done.
AdvaMed® Advancements: Q1 2025 Report
AdvaMed’s Q1 2025 report focuses on tariffs, policy action, and how we’re protecting Medtech innovation.
AdvaMed® Statement on President’s Reciprocal Tariff Pause
WASHINGTON – Today AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker:
Amendment To Reciprocal Tariffs and Updated Duties as Applied to Low-Value Imports from The People’s Republic of China
Details a sweeping tariff hike to 84% on Chinese imports and de minimis increases, aiming to protect U.S. economic and national security.
U.S. National Security & Business: Navigating Sanctions, Export Controls, CFIUS, and Outbound Investment Under the Trump Administration
Akin will provide a CLE program covering the latest legal issues for inbound trade and investment, including the Trump Administration’s approach to trade policy and tariff issues, and strategies medical…
AdvaMed®, Nine Other Organizations Urge Tariff Exemption for Medical Products
Washington, D.C.– AdvaMed, The Medtech Association®, and nine additional organizations urged an exemption from tariffs for medical and dental supplies, equipment, and devices, citing concerns about increased costs resulting in supply…
AdvaMed® Statement on Today’s Tariff Announcement
Washington, D.C.– AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker: “Our country is the birthplace of the medical device and technology industry and leads the…
AdvaMed®’s Medical Innovation Agenda for the 119th Congress
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.